Commentary

Video

Precision Epigenetic Targeting for Germinal Cancer Lymphomas

Author(s):

Jennifer Effie Amengual, MD

Jennifer Effie Amengual, MD, of Columbia University Hebert Irving Comprehensive Cancer Center, discusses precision epigenetic targeting for germinal cancer lymphomas.

Related Videos
Reid Merryman, MD
Partow Kebriaei, MD
Sonali M. Smith, MD
Grzegorz S. Nowakowski, MD
Marco Davila, MD, PhD
Geoffrey Shouse, DO, PhD
Geoffrey Shouse, DO, PhD
Danielle E. Hammond, MD, FRCP(C)
Eunice Wang, MD
Grzegorz S. Nowakowski, MD
Related Content
Non-Hodgkin Lymphoma | Image Credit: © freshidea - stock.adobe.com
September 6th 2024

Subcutaneous Rituximab Remains Underutilized in Non-Hodgkin Lymphoma

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Stefan K. Barta, MD, MS
September 5th 2024

Immunotherapy Could Represent New Treatment Avenue in T-Cell Lymphoma

Matthew Lunning, DO, FACP
October 30th 2023

Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

Stefano Luminari, MD
August 26th 2024

EU Greenlights Odronextamab for R/R Follicular Lymphoma and DLBCL

Jan van de Winkel, PhD, of Genmab
August 20th 2024

Epcoritamab Wins EU Approval for Relapsed/Refractory Follicular Lymphoma